Objectives To examine the response to single-day intravenous pamidronate in a
heterogeneous population with symptomatic osteoporosis. Study design Patients (n= 18) 6 …

Objective Because children with rheumatic disease receiving longterm corticosteroids are at
high risk for developing osteoporosis, we attempted to determine whether nutritional …

Context: As awareness of osteoporosis in childhood has increased, so have pressures to
consider use of the pharmacological agents used to treat osteoporosis in adults. This review …

OBJECTIVE: To describe the frequency of abnormal bone mineralization in a population of
children with juvenile systemic lupus erythematosus (JSLE), juvenile dermatomyositis …

Objective To identify biochemical predictors of spinal bone mineral growth and the
development of spinal osteoporosis in children with juvenile chronic arthritis (JCA) treated …

Context: Alendronate (ALN) is a bisphosphonate compound that can be administered orally
and has potential use in pediatric osteoporotic conditions. Objective: The objective was to …

There has been a major interest in the drug treatment of osteoporosis and an increase in the
number of drugs available in most countries. The ideal drug (one which increases or …

Osteoporosis can be thought of as a disease of childhood with manifestations in the adult
years. One strategy in prevention of osteoporosis is to maximize peak bone mass with …

OBJECTIVE: Oral alendronate sodium is a potent, specific inhibitor of osteoclast-mediated
bone resorption. To assess its efficacy and safety, a 3-year, randomized, double-blind …

Aim: To study the safety and efficacy of zole-dronic acid treatment in children with
ostcoporotic bone disorders. Study design: Observational study in 22 patients with …